Cytoskeleton and CRMPs in Neuronal Morphogenesis and Neurological Diseases: Potential Targets for New Therapies

Cytoskeletal proteins, and the molecules that control their assembly/disassembly, regulate neurite and spine growth and retraction, which are necessary for normal brain function. The neuron begins as a spherical shape, then lamellipodia and filopodia form nascent neurites which differentiate into dendrites and axons. These processes, also involved in neuronal plasticity, require changes in the dynamics of the cytoskeleton proteins and their intracellular binding partners, including collapsin-response mediator proteins (CRMPs). Abnormal changes in CRMP signaling induce structural/ functional abnormalities in neurons which are characteristics of various neurological disorders. Modulation of these pathways may represent unexplored areas for treatment of these diseases.

[1]  Ki Duk Park,et al.  (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5 , 2016, Molecular Neurobiology.

[2]  R. Møller,et al.  The contribution of next generation sequencing to epilepsy genetics , 2015, Expert review of molecular diagnostics.

[3]  C. Hoogenraad,et al.  The axonal cytoskeleton: from organization to function , 2015, Front. Mol. Neurosci..

[4]  F. Bradke,et al.  Coordinating Neuronal Actin–Microtubule Dynamics , 2015, Current Biology.

[5]  M. Khanna,et al.  A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors , 2015, Pain.

[6]  J. Honnorat,et al.  CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases , 2015, Molecular Psychiatry.

[7]  O. Hardiman,et al.  End-of-life management in patients with amyotrophic lateral sclerosis , 2015, The Lancet Neurology.

[8]  G. Bashaw,et al.  Transcription factors and effectors that regulate neuronal morphology , 2014, Development.

[9]  Fang Wu,et al.  Urokinase-Type Plasminogen Activator Promotes Dendritic Spine Recovery and Improves Neurological Outcome Following Ischemic Stroke , 2014, The Journal of Neuroscience.

[10]  J. Trojanowski,et al.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease. , 2014, Bioorganic & medicinal chemistry.

[11]  Shun-ying Yu,et al.  Synaptic proteins and receptors defects in autism spectrum disorders , 2014, Front. Cell. Neurosci..

[12]  F. de Winter,et al.  ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease , 2014, Front. Neurosci..

[13]  M. Rasband,et al.  Axon initial segments: diverse and dynamic neuronal compartments , 2014, Current Opinion in Neurobiology.

[14]  I. Fournier,et al.  Human temporal lobe epilepsy analyses by tissue proteomics , 2014, Hippocampus.

[15]  A. McGee,et al.  Convergent synaptic and circuit substrates underlying autism genetic risks , 2014, Frontiers in Biology.

[16]  N. Ip,et al.  CRMP2: functional roles in neural development and therapeutic potential in neurological diseases. , 2014, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[17]  R. Khanna,et al.  Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides , 2013, Neuroscience Letters.

[18]  Y. Goshima,et al.  Mice lacking collapsin response mediator protein 1 manifest hyperactivity, impaired learning and memory, and impaired prepulse inhibition , 2013, Front. Behav. Neurosci..

[19]  Hongwei Yu,et al.  Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion , 2013, Gene Therapy.

[20]  B. Nolen,et al.  Dip1 Defines a Class of Arp2/3 Complex Activators that Function without Preformed Actin Filaments , 2013, Current Biology.

[21]  J. Honnorat,et al.  Mapping CRMP3 domains involved in dendrite morphogenesis and voltage-gated calcium channel regulation , 2013, Journal of Cell Science.

[22]  I. Hertz-Picciotto,et al.  Autism-specific maternal autoantibodies recognize critical proteins in developing brain , 2013, Translational Psychiatry.

[23]  Wim Robberecht,et al.  The changing scene of amyotrophic lateral sclerosis , 2013, Nature Reviews Neuroscience.

[24]  R. Khanna,et al.  Suppression of pain‐related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine‐conjugated CRMP2 peptide , 2013, Journal of neurochemistry.

[25]  J. Trojanowski,et al.  Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies. , 2012, Journal of medicinal chemistry.

[26]  T. Abe,et al.  CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus , 2012, Developmental neurobiology.

[27]  L. Mucke,et al.  Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.

[28]  Y. Wang,et al.  Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization , 2012, Neuroscience.

[29]  Minfei Wu,et al.  The role of microtubule-associated protein 1B in axonal growth and neuronal migration in the central nervous system , 2012, Neural regeneration research.

[30]  J. Honnorat,et al.  The Collapsin Response Mediator Protein 5 Onconeural Protein Is Expressed in Schwann Cells Under Axonal Signals and Regulates Axon–Schwann Cell Interactions , 2012, Journal of neuropathology and experimental neurology.

[31]  J. Trojanowski,et al.  The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice , 2012, The Journal of Neuroscience.

[32]  M. Khanna,et al.  A peptide uncoupling CRMP-2 from the presynaptic Ca2+ channel complex demonstrates efficacy in animal models of migraine and AIDS therapy-induced neuropathy , 2012, Translational neuroscience.

[33]  Y. Goshima,et al.  Collapsin Response Mediator Proteins Regulate Neuronal Development and Plasticity by Switching Their Phosphorylation Status , 2012, Molecular Neurobiology.

[34]  S. Meroueh,et al.  CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy , 2012, Molecular pain.

[35]  C. Lajonchere,et al.  Genetic heritability and shared environmental factors among twin pairs with autism. , 2011, Archives of general psychiatry.

[36]  J. Honnorat,et al.  Effect of CRMP3 expression on dystrophic dendrites of hippocampal neurons , 2011, Molecular Psychiatry.

[37]  S. Meroueh,et al.  Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complex , 2011, Nature Medicine.

[38]  F. Bradke,et al.  Neuronal polarization: The cytoskeleton leads the way , 2011, Developmental neurobiology.

[39]  E. Melamed,et al.  The “Dying-Back” Phenomenon of Motor Neurons in ALS , 2011, Journal of Molecular Neuroscience.

[40]  K. Hanada,et al.  Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases , 2010, Proteome Science.

[41]  J. Honnorat,et al.  CRMP5 Interacts with Tubulin to Inhibit Neurite Outgrowth, Thereby Modulating the Function of CRMP2 , 2010, The Journal of Neuroscience.

[42]  Eun-Mi Hur,et al.  GSK3 signalling in neural development , 2010, Nature Reviews Neuroscience.

[43]  B. Pettmann,et al.  Collapsin Response Mediator Protein 4a (CRMP4a) Is Upregulated in Motoneurons of Mutant SOD1 Mice and Can Trigger Motoneuron Axonal Degeneration and Cell Death , 2010, The Journal of Neuroscience.

[44]  K. Fukami,et al.  MARCKS regulates lamellipodia formation induced by IGF‐I via association with PIP2 and β‐actin at membrane microdomains , 2009, Journal of cellular physiology.

[45]  G. Bloom,et al.  Cytoskeletal pathologies of Alzheimer disease. , 2009, Cell motility and the cytoskeleton.

[46]  J. Honnorat,et al.  Altered expression of CRMPs in the brain of bovine spongiform encephalopathy-infected mice during disease progression , 2009, Brain Research.

[47]  K. Arima,et al.  Prion disease causes less severe lesions in human hippocampus than other parts of brain , 2008, Psychiatry and clinical neurosciences.

[48]  L. Qiang,et al.  The microtubule-severing proteins spastin and katanin participate differently in the formation of axonal branches. , 2008, Molecular biology of the cell.

[49]  I. Fournier,et al.  MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting. , 2008, Journal of proteome research.

[50]  M. Baudry,et al.  The FASEB Journal • Research Communication CRMP3 is required for hippocampal CA1 dendritic organization and plasticity , 2022 .

[51]  A. Verkhratsky,et al.  Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression , 2007, Journal of neurochemistry.

[52]  J. Shih,et al.  Mice Deficient in Collapsin Response Mediator Protein-1 Exhibit Impaired Long-Term Potentiation and Impaired Spatial Learning and Memory , 2007, The Journal of Neuroscience.

[53]  M. Pool,et al.  Identification of CRMP4 as a Convergent Regulator of Axon Outgrowth Inhibition , 2007, The Journal of Neuroscience.

[54]  M. Sheng,et al.  The growing role of mTOR in neuronal development and plasticity , 2006, Molecular Neurobiology.

[55]  Paul M. Thompson,et al.  In vivo neuropathology of the hippocampal formation in AD: A radial mapping MR-based study , 2006, NeuroImage.

[56]  T. Takenawa,et al.  CRMP-2 Is Involved in Kinesin-1-Dependent Transport of the Sra-1/WAVE1 Complex and Axon Formation , 2005, Molecular and Cellular Biology.

[57]  V. Gribkoff,et al.  Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain. , 2005, Biochemical pharmacology.

[58]  S. Prusiner,et al.  Notch-1 activation and dendritic atrophy in prion disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  K. Kaibuchi,et al.  GSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal Polarity , 2005, Cell.

[60]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[61]  J. Honnorat,et al.  Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons , 2004, Molecular and Cellular Neuroscience.

[62]  Azad Bonni,et al.  A CaMKII-NeuroD Signaling Pathway Specifies Dendritic Morphogenesis , 2004, Neuron.

[63]  A. Barthelaix,et al.  Stable Tubule Only Polypeptides (STOP) Proteins Co‐Aggregate with Spheroid Neurofilaments in Amyotrophic Lateral Sclerosis , 2003, Journal of neuropathology and experimental neurology.

[64]  K. Kaibuchi,et al.  CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth , 2003, Nature Cell Biology.

[65]  Gary G. Borisy,et al.  Mechanism of filopodia initiation by reorganization of a dendritic network , 2003, The Journal of cell biology.

[66]  R. J. Dumont,et al.  Acute Spinal Cord Injury, Part II: Contemporary Pharmacotherapy , 2001, Clinical neuropharmacology.

[67]  Liqun Luo,et al.  How do dendrites take their shape? , 2001, Nature Neuroscience.

[68]  J. Honnorat,et al.  Paraneoplastic disorders of the central and peripheral nervous systems. , 2014, Handbook of clinical neurology.

[69]  G. Gallo,et al.  Cytoskeletal and signaling mechanisms of neurite formation , 2014, Cell and Tissue Research.

[70]  G. Gallo.  Mechanisms underlying the initiation and dynamics of neuronal filopodia: from neurite formation to synaptogenesis. , 2013, International review of cell and molecular biology.

[71]  D. Mann,et al.  CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases. , 2011, Journal of Alzheimer's disease : JAD.

[72]  Malgorzata Urbanska,et al.  Molecular basis of dendritic arborization. , 2008, Acta neurobiologiae experimentalis.

[73]  F. Dudek,et al.  Epileptogenesis in the dentate gyrus: a critical perspective. , 2007, Progress in brain research.